September 1, 2011 | By Ashley Post
The high court's Pliva v. Mensing decision shields generic-medication companies from failure-to-warn claims.
Most Popular Articles
From Bloomberg BNA
From Merrill DataSite
From Click 4 Compliance
From AllClear ID
From FTI Technology
From HP eDiscovery
September 22, 2015 at 2:00 pm ET
October 20, 2015 at 2:00 pm ET
Get the latest business trends, current corporate litigation, labor developments, technology initiatives and more.
Sign up to receive InsideScoop — FREE
You have been subscribed! You will receive a confirmation email soon.